Anti-CD20 therapy

Anti-CD20 therapy involves using medications that target a specific protein called CD20 found on certain immune cells called B cells. B cells are part of the immune system and can sometimes mistakenly attack the body's own tissues, as in autoimmune diseases, or help cancer cells grow. By attaching to CD20, these therapies effectively reduce or eliminate harmful B cells, helping to control disease activity. This treatment is used for conditions like multiple sclerosis and certain blood cancers. It’s generally administered through infusions and aims to modulate the immune response without broadly suppressing overall immune function.